Sugisawa N - Search Results

1

A Phenylfurocoumarin Derivative Reverses ABCG2-Mediated Multidrug Resistance In Vitro and In Vivo.

Kokubo S, Ohnuma S, Murakami M, Kikuchi H, Funayama S, Suzuki H, Kajiwara T, Yamamura A, Karasawa H, Sugisawa N, Ohsawa K, Kano K, Aoki J, Doi T, Naitoh T, Ambudkar SV, Unno M. Kokubo S, et al. Among authors: sugisawa n. Int J Mol Sci. 2021 Nov 19;22(22):12502. doi: 10.3390/ijms222212502. Int J Mol Sci. 2021. PMID: 34830383 Free PMC article.

2

Synthetic Analogs of Curcumin Modulate the Function of Multidrug Resistance-Linked ATP-Binding Cassette Transporter ABCG2.

Murakami M, Ohnuma S, Fukuda M, Chufan EE, Kudoh K, Kanehara K, Sugisawa N, Ishida M, Naitoh T, Shibata H, Iwabuchi Y, Ambudkar SV, Unno M. Murakami M, et al. Among authors: sugisawa n. Drug Metab Dispos. 2017 Nov;45(11):1166-1177. doi: 10.1124/dmd.117.076000. Epub 2017 Sep 13. Drug Metab Dispos. 2017. PMID: 28904007 Free PMC article.

3

Lymph nodes around the posterior gastric artery: their existence, frequency, and clinical implications.

Ishii K, Ishida M, Sugisawa N, Murakami M, Ono T, Tachibana T, Imoto H, Aoki T, Kudoh K, Ohnuma S, Sakata N, Musha H, Morikawa T, Motoi F, Kamei T, Naitoh T, Unno M. Ishii K, et al. Among authors: sugisawa n. Surg Today. 2018 Oct;48(10):916-920. doi: 10.1007/s00595-018-1677-0. Epub 2018 Jun 4. Surg Today. 2018. PMID: 29869067

4

Novel Potent ABCB1 Modulator, Phenethylisoquinoline Alkaloid, Reverses Multidrug Resistance in Cancer Cell.

Sugisawa N, Ohnuma S, Ueda H, Murakami M, Sugiyama K, Ohsawa K, Kano K, Tokuyama H, Doi T, Aoki J, Ishida M, Kudoh K, Naitoh T, Ambudkar SV, Unno M. Sugisawa N, et al. Mol Pharm. 2018 Sep 4;15(9):4021-4030. doi: 10.1021/acs.molpharmaceut.8b00457. Epub 2018 Aug 13. Mol Pharm. 2018. PMID: 30052463 Free PMC article.

5

Combination therapy of tumor-targeting Salmonella typhimurium A1-R and oral recombinant methioninase regresses a BRAF-V600E-negative melanoma.

Kawaguchi K, Higuchi T, Li S, Han Q, Tan Y, Igarashi K, Zhao M, Miyake K, Kiyuna T, Miyake M, Ohshiro H, Sugisawa N, Zhang Z, Razmjooei S, Wangsiricharoen S, Chmielowski B, Nelson SD, Russell TA, Dry SM, Li Y, Eckardt MA, Singh AS, Singh SR, Eilber FC, Unno M, Hoffman RM. Kawaguchi K, et al. Among authors: sugisawa n. Biochem Biophys Res Commun. 2018 Sep 18;503(4):3086-3092. doi: 10.1016/j.bbrc.2018.08.097. Epub 2018 Aug 27. Biochem Biophys Res Commun. 2018. PMID: 30166061

6

Induction of Metastasis by Low-dose Gemcitabine in a Pancreatic Cancer Orthotopic Mouse Model: An Opposite Effect of Chemotherapy.

Sugisawa N, Miyake K, Higuchi T, Oshiro H, Zhang Z, Park JH, Kawaguchi K, Chawla SP, Bouvet M, Singh SR, Unno M, Hoffman RM. Sugisawa N, et al. Anticancer Res. 2019 Oct;39(10):5339-5344. doi: 10.21873/anticanres.13726. Anticancer Res. 2019. PMID: 31570427

7

Adjuvant Oral Recombinant Methioninase Inhibits Lung Metastasis in a Surgical Breast-Cancer Orthotopic Syngeneic Model.

Sugisawa N, Hamada K, Han Q, Yamamoto J, Sun YU, Nishino H, Kawaguchi K, Bouvet M, Unno M, Hoffman RM. Sugisawa N, et al. Anticancer Res. 2020 Sep;40(9):4869-4874. doi: 10.21873/anticanres.14489. Anticancer Res. 2020. PMID: 32878774

8

A Gemcitabine Plus 5-Fluorouracil Combination Inhibits Gastric-Cancer Liver Metastasis in a PDOX Model: A Novel Treatment Strategy.

Sugisawa N, Nishino H, Higuchi T, Park JH, Yamamoto J, Tashiro Y, Kawaguchi K, Bouvet M, Unno M, Hoffman RM. Sugisawa N, et al. Anticancer Res. 2020 Oct;40(10):5393-5397. doi: 10.21873/anticanres.14547. Anticancer Res. 2020. PMID: 32988858

9

Triple-Methyl Blockade With Recombinant Methioninase, Cycloleucine, and Azacitidine Arrests a Pancreatic Cancer Patient-Derived Orthotopic Xenograft Model.

Sugisawa N, Yamamoto J, Han Q, Tan Y, Tashiro Y, Nishino H, Inubushi S, Hamada K, Kawaguchi K, Unno M, Bouvet M, Hoffman RM. Sugisawa N, et al. Pancreas. 2021 Jan 1;50(1):93-98. doi: 10.1097/MPA.0000000000001709. Pancreas. 2021. PMID: 33370029

10

Oral recombinant methioninase combined with paclitaxel arrests recalcitrant ovarian clear cell carcinoma growth in a patient-derived orthotopic xenograft (PDOX) nude-mouse model.

Sugisawa N, Higuchi T, Han Q, Hozumi C, Yamamoto J, Tashiro Y, Nishino H, Kawaguchi K, Bouvet M, Murata T, Unno M, Hoffman RM. Sugisawa N, et al. Cancer Chemother Pharmacol. 2021 Jul;88(1):61-67. doi: 10.1007/s00280-021-04261-x. Epub 2021 Mar 25. Cancer Chemother Pharmacol. 2021. PMID: 33768300

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

82 results

Search Page